HONG KONG – China is on track to achieve some major milestones in biotechnology by 2020, further accelerating the growth of its drug development sector. Despite numerous challenges, the outlook for China’s pharmaceutical industry remains very positive as the country aggressively implements reforms, according to industry analysts.